Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia

NCT05295784 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT05295784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05295784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
Lead sponsor
University of Arkansas
Phase
Phase 1
Overall status
Withdrawn
Start date
May 8, 2024
Completion date
May 8, 2024
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, caffeine, hypoxic-ischemic encephalopathy